Fosamax Plus D and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Fosamax Plus D and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alendronate / cholecalciferol
Brand name: Fosamax Plus D
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosamax Plus D-Insulin degludec
- Fosamax Plus D-Insulin Degludec (U-100) Prefilled Pens
- Fosamax Plus D-Insulin Degludec (U-100) Vials
- Fosamax Plus D-Insulin Degludec (U-200) Prefilled Pens
- Fosamax Plus D-Insulin degludec and liraglutide
- Fosamax Plus D-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Fosamprenavir
- Insulin aspart, recombinant Subcutaneous-Fosamprenavir Calcium
- Insulin aspart, recombinant Subcutaneous-Fosamprenavir Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Fosamprenavir Tablets
- Insulin aspart, recombinant Subcutaneous-Fosaprepitant
- Insulin aspart, recombinant Subcutaneous-Fosaprepitant Injection